Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.

Hillenkamp, J

Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. [electronic resource] - Archives of ophthalmology (Chicago, Ill. : 1960) Oct 2001 - 1487-91 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0003-9950

10.1001/archopht.119.10.1487 doi


Acute Disease
Adenovirus Infections, Human--drug therapy
Adenoviruses, Human--genetics
Administration, Topical
Adult
Aged
Aged, 80 and over
Antiviral Agents--administration & dosage
Cidofovir
Cyclosporine--administration & dosage
Cytosine--administration & dosage
DNA Primers--chemistry
DNA, Viral--analysis
Double-Blind Method
Drug Evaluation
Drug Therapy, Combination
Eye Infections, Viral--drug therapy
Female
Humans
Immunosuppressive Agents--administration & dosage
Keratoconjunctivitis--drug therapy
Male
Middle Aged
Ophthalmic Solutions
Organophosphonates
Organophosphorus Compounds--administration & dosage
Pilot Projects
Polymerase Chain Reaction
Treatment Outcome